Amphastar Pharma Stock (NASDAQ: AMPH) stock price, news, charts, stock research, profile.
Open | $39.25 |
Close | - |
Volume / Avg. | 42.98K / 362.88K |
Day Range | 39.25 - 40.14 |
52 Wk Range | 36.56 - 67.66 |
Market Cap | $1.96B |
P/E Ratio | 13.55 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 12.98% |
Days to Cover | 12.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amphastar Pharma (NASDAQ:AMPH) through any online brokerage.
Other companies in Amphastar Pharma’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
There is no analysis for Amphastar Pharma.
Amphastar Pharma has a consensus price target of $58.67.
The stock price for Amphastar Pharma (NASDAQ: AMPH) is $40.15 last updated Today at July 18, 2024 at 11:19 AM EDT.
There are no upcoming dividends for Amphastar Pharma.
Amphastar Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Amphastar Pharma.
Amphastar Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.